middle.news
AdAlta’s CAR-T Therapy Delivers Rare Tumour Disappearances in Mesothelioma Trial
9:30am on Wednesday 1st of April, 2026 AEDT
•
Healthcare
Read Story
AdAlta’s CAR-T Therapy Delivers Rare Tumour Disappearances in Mesothelioma Trial
9:30am on Wednesday 1st of April, 2026 AEDT
Key Points
50% overall response rate at higher BZDS1901 doses
20% of patients achieved complete tumour disappearance
14 advanced mesothelioma patients treated after failing prior therapies
Improved safety profile enables exploration of increased dosing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ADALTA (ASX:1AD)
OPEN ARTICLE